Tingbing Cao
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
PCSK9 in peripheral arterial disease: Mechanisms and therapeutic perspectives.
Journal: Science progress
Published: September 16, 2025
SIRT3 Represses Vascular Remodeling via Reducing Mitochondrial Ac-CoA Accumulation in Vascular Smooth Muscle Cells.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: April 17, 2025
Endothelial SIRT3 deficiency predisposes brown adipose tissue to whitening in diet-induced obesity.
Journal: International journal of biological sciences
Published: January 19, 2025
Meriones unguiculatus serves as a spontaneous primary aldosteronism rodent model.
Journal: PloS one
Published: July 29, 2024
Dietary apigenin ameliorates obesity-related hypertension through TRPV4-dependent vasorelaxation and TRPV4-independent adiponectin secretion.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: June 05, 2024
Dietary Cinnamaldehyde Activation of TRPA1 Antagonizes High-Salt-Induced Hypertension Through Restoring Renal Tubular Mitochondrial Dysfunction.
Journal: American journal of hypertension
Published: January 17, 2024
Sodium-glucose exchanger 2 inhibitor canagliflozin promotes mitochondrial metabolism and alleviates salt-induced cardiac hypertrophy via preserving SIRT3 expression.
Journal: Journal of advanced research
Published: January 17, 2024
Leptin receptor deficiency impedes metabolic surgery related-weight loss through inhibition of energy expenditure in db/db mice.
Journal: Diabetology & metabolic syndrome
Published: December 05, 2023
Artemisinin alleviates obesity-related glomerulopathy by downregulating CYP24A1 expression.
Journal: Diabetes, obesity & metabolism
Published: August 22, 2023
Cx43 acts as a mitochondrial calcium regulator that promotes obesity by inducing the polarization of macrophages in adipose tissue.
Journal: Cellular signalling
Published: November 06, 2022
Sodium-Glucose Cotransporter 2 Inhibitor Canagliflozin Antagonizes Salt-Sensitive Hypertension Through Modifying Transient Receptor Potential Channels 3 Mediated Vascular Calcium Handling.
Journal: Journal of the American Heart Association
Published: July 29, 2022
Last Updated: 09/26/2026